Responses
Abstracts accepted for publication
Rheumatoid arthritis - non biologic treatment
AB0356 Treat to target in early rheumatoid arthritis clinic (eac): remission rates on combination of leflunomide, hydroxychloroquine and methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.